Submitted for Publication: December 23, 2011; final revision received March 15, 2012; accepted March 19, 2012.
Published Online: May 14, 2012. doi:10.1001/archophthalmol.2012.1043
Author Contributions: All authors had full access to the data and contributed to the interpretation of the data and the writing and approval of the manuscript. Dr Ip made the final decision to submit the manuscript.
Financial Disclosure: Dr Ip is a consultant/advisor for Eye Technology Ltd, Genentech Inc, NicOx, Notal Vision, QLT Phototherapeutics Inc, Regeneron, and Sirion and has received grant support from Allergan Inc. Drs Hopkins and Ehrlich and Ms Wong are employees of Genentech Inc, a member of the Roche Group. Drs Hopkins and Ehrlich hold equity and/or options in Roche.
Funding/Support: This study was supported by Genentech Inc. Support for third-party writing assistance by Ivo Stoilov, MD, CMPP, of Envision Scientific Solutions was provided by Genentech Inc.
Role of the Sponsor: The sponsor participated in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation and review of the manuscript.